TARAFEN

Medicinal product

(Invented) name

TARAFEN

Active substance (s)

Paracetamolis/Pseudoefedrino hidrochloridas/Dekstrometorfano hidrobromidas

Strength

500 mg/30 mg/15 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

ATC code (s)

N02BE51, Paracetamol, combinations excl. psycholeptics

Marketing authorisation holder

UAB Eletis Pharma, Lietuva

Date of authorisation

2015-10-16

Date of renewal

2021-02-18

Documents

Stage

Perregistruotas

Controlled?

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Paracetamolis	500 mg
Pseudoefedrino hidrochloridas	30 mg
Dekstrometorfano hidrobromidas	15 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
61543	75884	1075884	lizdinė plokštelė	N10		Nereceptinis	LT/1/15/3819/001	Netiekiama	-	-	No	-	-	Download
63960	78405	1078405	lizdinė plokštelė	N20		Nereceptinis	LT/1/15/3819/002	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-02-18	Perregistruotas
2015-10-16	Registruotas